Oculopharyngeal Muscular Dystrophy (OPMD) Overview

Definition

Oculopharyngeal Muscular Dystrophy (OPMD) is a rare genetic muscle disorder characterized by progressive weakness of the muscles controlling the eyes (oculo-) and throat (pharyngeal), as well as other skeletal muscles. It typically begins in adulthood.

Causes

• Genetic Mutation: OPMD is caused by a mutation in the PABPN1 gene.

• Inheritance Pattern: Most commonly autosomal dominant (one copy of the mutated gene is enough), but autosomal recessive forms also exist.

Onset

• Typically appears between the ages of 40 and 60.

Symptoms

• Ptosis: Drooping eyelids (often bilateral)

• Dysphagia: Difficulty swallowing, which may worsen over time

• Weakness in Proximal Limb Muscles: Especially in shoulders and hips

• Choking or nasal regurgitation during eating

• Facial muscle weakness (in some cases)

Diagnosis

• Clinical Evaluation: Observation of ptosis, dysphagia, family history

• Genetic Testing: Confirms PABPN1 gene mutation

• Muscle Biopsy: May show rimmed vacuoles or inclusions

• Electromyography (EMG): Indicates myopathic changes

Treatment

There is no cure, but management focuses on symptom relief:

Supportive Therapies

• Eyelid surgery (blepharoplasty) for ptosis

• Swallowing therapy with speech-language pathologists

• Feeding tube (PEG) placement in severe dysphagia

• Physical therapy to maintain mobility

Medications

• No specific medications to stop disease progression

• Nutritional support and anti-reflux therapy may help

Prognosis

• Progressive but slow; many individuals live a normal lifespan

• Quality of life can be significantly affected by dysphagia and muscle weakness

Prevention

• Genetic counseling recommended for affected individuals and their families